Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases

Open Access

Peer-reviewed

Research Article

Hyo-Jeong Lee,

Affiliation Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea
⨯
Jeong-Yoon Lee,

Affiliation Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea
⨯
Min-Hee Park,

Affiliation Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea
⨯
Joo-Young Kim,

Affiliation Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea
⨯
Jun Chang

* E-mail: tcell@ewha.ac.kr

Affiliation Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea

http://orcid.org/0000-0002-8423-5987

⨯

Reader Comments (0)

Prophylaxis
Is the Subject Area "Prophylaxis" applicable to this article?

Thanks for your feedback.
Cysteine
Is the Subject Area "Cysteine" applicable to this article?

Thanks for your feedback.
Monoclonal antibodies
Is the Subject Area "Monoclonal antibodies" applicable to this article?

Thanks for your feedback.
Viral vaccines
Is the Subject Area "Viral vaccines" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Recombinant proteins
Is the Subject Area "Recombinant proteins" applicable to this article?

Thanks for your feedback.